Vaccine Maker AstraZeneca Puts Hold on Clinical Trials After Participant Falls Ill

<p>We had a setback this week in vaccine development as AstraZeneca and Oxford University put a hold on stage three clinical trials of their experimental COVID-19 vaccine. One participant in the U.K. came down with an unexplained illness forcing the trial to shut down while an investigation is done. Rebecca Robbins, reporter at STAT News, joins us for what this pause means.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>